Skip to main content
VCbacked
Log inGet Started

GeneCentric Therapeutics

Durham, United States

GeneCentric Therapeutics develops and commercializes molecular diagnostic tests for oncologists and patients.

$8.0M raised
Jun 2025
Series C
BiotechnologyHealth CareHealth Diagnostics

Top Investors

LabCorpDow JonesHatteras Venture PartnersAlexandria Venture InvestmentsIAG Capital Partners

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about GeneCentric Therapeutics

How much funding has GeneCentric Therapeutics raised?
GeneCentric Therapeutics has raised $8.0M in total funding. The most recent round was Series C. The last funding was announced in June 2025.
Who are GeneCentric Therapeutics's investors?
GeneCentric Therapeutics's investors include LabCorp, Dow Jones, Hatteras Venture Partners, Alexandria Venture Investments, IAG Capital Partners.
Where is GeneCentric Therapeutics headquartered?
GeneCentric Therapeutics is headquartered in Durham, United States.
What does GeneCentric Therapeutics do?
GeneCentric Therapeutics develops and commercializes molecular diagnostic tests for oncologists and patients.
What stage is GeneCentric Therapeutics at?
GeneCentric Therapeutics is at the Series C stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"GeneCentric Therapeutics — Funding & Investors." VCBacked, June 18, 2025, https://www.vcbacked.co/company/genecentric-therapeutics. Accessed June 16, 2026.
APA
VCBacked. (2025). GeneCentric Therapeutics — Funding & Investors. Retrieved June 16, 2026, from https://www.vcbacked.co/company/genecentric-therapeutics
Wikipedia (cite web)
{{cite web |title=GeneCentric Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/genecentric-therapeutics |website=VCBacked |access-date=June 16, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong